Intronic Haplotypes in the GBA Gene Do Not Predict Age at Diagnosis of Parkinson's Disease.

TitleIntronic Haplotypes in the GBA Gene Do Not Predict Age at Diagnosis of Parkinson's Disease.
Publication TypeJournal Article
Year of Publication2021
AuthorsToffoli, M, Higgins, A, Lee, C, Koletsi, S, Chen, X, Eberle, M, Sedlazeck, FJ, Mullin, S, Proukakis, C, Schapira, AHV
JournalMov Disord
Volume36
Issue6
Pagination1456-1460
Date Published2021 Jun
ISSN1531-8257
KeywordsGlucosylceramidase, Haplotypes, Humans, Introns, Mutation, Parkinson Disease
Abstract

BACKGROUND: GBA mutations are a common risk factor for Parkinson's disease (PD). A recent study has suggested that GBA haplotypes, identified by intronic variants, can affect age at diagnosis of PD.

OBJECTIVES: In this study, we assess this hypothesis using long reads across a large cohort and the publicly available Accelerating Medicines Partnership-Parkinson's Disease (AMP-PD) cohort.

METHODS: We recruited a PD cohort through the Remote Assessment of Parkinsonism Supporting Ongoing Development of Interventions in Gaucher Disease study (RAPSODI) and sequenced GBA using Oxford Nanopore technology. Genetic and clinical data on the full AMP-PD cohort were obtained from the online portal of the consortium.

RESULTS: A total of 1417 participants were analyzed. There was no significant difference in age at PD diagnosis between the two main haplotypes of the GBA gene.

CONCLUSIONS: GBA haplotypes do not affect age at diagnosis of PD in the two independent cohorts studied. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

DOI10.1002/mds.28616
Alternate JournalMov Disord
PubMed ID34008887
PubMed Central IDPMC8436748
Grant List / / Cure Parkinson Trust /
/ / Kattan Trust /
IIR-GBR-001110 / / Takeda Pharmaceutical Company /
MR/M006646/1 / MRC_ / Medical Research Council / United Kingdom

Similar Publications